![The avni lab](https://static.wixstatic.com/media/b2ccdb_6e002b625f034c929623434ff05cddfb~mv2.png/v1/crop/x_0,y_1229,w_18930,h_5078/fill/w_231,h_62,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/b2ccdb_6e002b625f034c929623434ff05cddfb~mv2.png)
![The Role of iASPP in the Regulation of the Inflammatory Process](https://static.wixstatic.com/media/475bc6_7d9fc476d496477a97cf4d8fbc3a7096~mv2.png/v1/fill/w_929,h_352,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/475bc6_7d9fc476d496477a97cf4d8fbc3a7096~mv2.png)
The Role of iASPP in the Regulation of the Inflammatory Process
Dilated cardiomyopathy (DCM) is a life threatening disorder whose genetic basis is heterogeneous and mostly unknown. Five Arab-Christian-infants, ages 4-30 months from four families were diagnosed with DCM associated with mild skin, teeth and hair abnormalities. All passed away before age 3.
A homozygous sequence variation creating a premature stop codon at PPP1R13L encoding the iASPP protein, was identified in three infants, and in the mother of the other two. Patients’ fibroblasts and PPP1R13L-knocked down human fibroblasts presented higher expression levels of pro-inflammatory cytokine genes in response to Lipopolysaccharide, as well as ppp1r13l-knocked down murine cardiomyocytes and hearts of ppp1r13l-deficient mice.
​
The hypersensitivity to Lipopolysaccharide was NF-κB-dependent, and its inducible binding activity to promoters of pro-inflammatory cytokine genes was elevated in patients’ fibroblasts. RNA-sequencing of ppp1r13l-knocked down murine cardiomyocytes and of hearts derived from different stages of DCM development in ppp1r13l-deficient mice revealed the crucial role of iASPP in dampening cardiac inflammatory response. Our results determined PPP1R13L as the gene underlying a novel autosomal recessive cardio cutaneous syndrome in humans, and strongly suggest that the fatal DCM during infancy is a consequence of failure to regulate transcriptional pathways necessary for tuning cardiac threshold response to common inflammatory stressors.